This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2026
Grand Nikko Tokyo DaibaTokyo
メニュー

Hiroaki Suzuki
Vetter Pharma International Japan における Key Account Manager Japan
スピーカー

アジェンダセッション

  • Chairperson’s Remarks: Track 1

    , 10:55am
    セッションを見る

  • Chairperson's Remarks: Track 1

    , 1:40pm
    セッションを見る

このイベントで

前へ
次へ
Katsuto Tamai, M.D, PhD
CSO and Director of StemRIM Inc. and Guest Professor
Osaka University Graduate School of Medicine

Hiroaki を TIDES Asia: Oligonucleotide & Peptide Therapeutics で見る